These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22192147)

  • 1. Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles.
    Jacot W; Lopez-Crapez E; Thezenas S; Senal R; Fina F; Bibeau F; Romieu G; Lamy PJ
    Breast Cancer Res; 2011; 13(6):R133. PubMed ID: 22192147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell-free DNA of non-small cell lung cancer patients.
    Zaini J; Syahruddin E; Yunus M; Andarini SL; Hudoyo A; Masykura N; Yasril R; Ridwanuloh A; Hidajat H; Nurwidya F; Suharsono S; Utomo ARH
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1159. PubMed ID: 32721094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
    Teng YH; Tan WJ; Thike AA; Cheok PY; Tse GM; Wong NS; Yip GW; Bay BH; Tan PH
    Breast Cancer Res; 2011 Apr; 13(2):R35. PubMed ID: 21457545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
    BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-resolution melting analysis for the detection of EGFR mutations in circulating DNA of lung cancer patients].
    Zhao J; Peng QX; Yang BH; Lu DR
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(10):674-8. PubMed ID: 21600173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E; Jurado I; Hernan I; Gamundi MJ; Dias M; Martí I; Mañé B; Arcusa A; Agúndez JA; Blanca M; Carballo M
    BMC Cancer; 2011 Sep; 11():406. PubMed ID: 21943394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer.
    Sriram KB; Tan ME; Savarimuthu SM; Wright CM; Relan V; Stockwell RE; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
    Eur Respir J; 2011 Oct; 38(4):903-10. PubMed ID: 21349912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutation detection efficiency in EGFR: a comparison between high resolution melting analysis and Sanger sequencing.
    Joy RA; Thelakkattusserry SK; Vikkath N; Bhaskaran R; Krishnan S; Vasudevan D; Ariyannur PS
    BMC Cancer; 2020 Sep; 20(1):902. PubMed ID: 32962681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.
    Qin L; Zhong W; Zhang L; Li LY; Wang MZ
    Chin Med J (Engl); 2011 Mar; 124(6):887-91. PubMed ID: 21518597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EGFR- and HER2-activating mutations in squamous cell carcinoma involving the head and neck.
    Willmore-Payne C; Holden JA; Layfield LJ
    Mod Pathol; 2006 May; 19(5):634-40. PubMed ID: 16547470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of EGFR gene copy number changes and KRAS gene mutation status in Korean triple negative breast cancer patients.
    Kim Y; Kim J; Lee HD; Jeong J; Lee W; Lee KA
    PLoS One; 2013; 8(10):e79014. PubMed ID: 24205362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers.
    Jacot W; Mollevi C; Fina F; Lopez-Crapez E; Martin PM; Colombo PE; Bibeau F; Romieu G; Lamy PJ
    BMC Cancer; 2015 Dec; 15():986. PubMed ID: 26680641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
    Leidner RS; Fu P; Clifford B; Hamdan A; Jin C; Eisenberg R; Boggon TJ; Skokan M; Franklin WA; Cappuzzo F; Hirsch FR; Varella-Garcia M; Halmos B
    J Clin Oncol; 2009 Nov; 27(33):5620-6. PubMed ID: 19786660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Kim HJ; Lee KY; Kim YC; Kim KS; Lee SY; Jang TW; Lee MK; Shin KC; Lee GH; Lee JC; Lee JE; Kim SY
    Lung Cancer; 2012 Mar; 75(3):321-5. PubMed ID: 21930325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.
    Hashida S; Soh J; Toyooka S; Tanaka T; Furukawa M; Shien K; Yamamoto H; Asano H; Tsukuda K; Hagiwara K; Miyoshi S
    Oncol Rep; 2014 Jul; 32(1):145-52. PubMed ID: 24842519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine.
    Lamy PJ; Jacot W
    Diagn Pathol; 2012 Feb; 7():13. PubMed ID: 22293080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.
    Martínez-Carretero C; Pascual FI; Rus A; Bernardo I
    Clin Chem Lab Med; 2017 Oct; 55(12):1970-1978. PubMed ID: 28432840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
    O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
    BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck.
    Schwentner I; Witsch-Baumgartner M; Sprinzl GM; Krugmann J; Tzankov A; Jank S; Zwierzina H; Loeffler-Ragg J
    Head Neck; 2008 Aug; 30(8):1040-4. PubMed ID: 18528899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.
    Grob TJ; Heilenkötter U; Geist S; Paluchowski P; Wilke C; Jaenicke F; Quaas A; Wilczak W; Choschzick M; Sauter G; Lebeau A
    Breast Cancer Res Treat; 2012 Jul; 134(2):561-7. PubMed ID: 22610646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.